on

Learn About Influenza Myths on Webcast

by

OSUWexnerbloglogo2014 Learn About Influenza Myths on Webcast. We recently had infectious disease specialist and Assistant Professor of Internal Medicine Dr. Mahdee Sobhanie on our webcast discussing Influenza. He and our moderator, Dr. Jim Allen, had an interesting Q and A about common Influenza myths. See what our expert had to say in the video below.

Learn about influenza myths


You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches On Vaccine Preventable Diseases

by

OSUWexnerbloglogo2014 CME Webcast Teaches On Vaccine Preventable Diseases. On this webcast, we are going to re-acquaint you with some diseases that 40 years ago, physicians expected to be eradicated. In many cases, these disease are not only not eradicated but they are increasing in incidence. Joining our moderator in the studio is infectious disease specialist at Nationwide Children’s Hospital and Assistant Professor of Pediatrics from the Ohio State University, Dr. Matthew Washam.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the clinical presentation of measles, mumps, and hepatitis A infection; and UNDERSTAND how to interpret testing results for measles, mumps, and hepatitis A virus.

You’ll also learn about the following:

  • Measles in the United States
  • Vaccine effectiveness
  • Autism and vaccines
  • Egg allergy and the MMR vaccine

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches on Preventive Cardiology

by

OSUWexnerbloglogo2014 CME Webcast Teaches on Preventive Cardiology. The best way to improve outcomes in cardiovascular disease is to not get it in the first place and today on MedNet21, we are going to show you what you can do to prevent heart disease in your patients. Let me welcome today’s guests. Dr. Wesley Milks is a cardiologist and Assistant Professor of Internal Medicine and Kelly Bartsch is a pharmacist specializing in lipid management.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW
the mechanisms of action of the major medication classes utilized in the 2018 multi-society cholesterol guidelines; and UNDERSTAND the influence of the new cardiovascular outcomes trials for ezetimibe and the PCSK9 inhibitors on the new cholesterol guidelines; DEMONSTRATE understanding of key atherosclerotic risk and risk-enhancing factors as well as of recent pivotal lipid lowering treatment guidelines; and SELECT the appropriate target of lipid lowering therapy (e.g. LDL-C or non-HDL-C) with respect to the patient’s comorbid metabolic conditions.

You’ll also learn about the following:

  • Cholesterol level goals
  • Indications for medical treatment of lipids
  • Follow-up of patients started on cholesterol lowering drugs
  • Monitoring of cholesterol lowering drugs
  • CRP and other inflammatory markers

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Advances in Liver Disease on CME Webcast

by

OSUWexnerbloglogo2014 Learn About Advances in Liver Disease on CME Webcast. On this CME webcast, we’re going to hear about the latest chapter in the hepatitis C saga, that is, the treatment of hepatitis C. And we’re also going to hear about some of the other emerging liver diseases that you are likely to encounter in your clinical practice and some of the tools hepatologists use to evaluate liver conditions. Let me welcome today’s guests, both hepatologists from the Ohio State University. Dr. James Hanje is an Associate Professor of Internal Medicine and Dr. Anthony Michaels is also an Associate Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Recognize the change in patient population in patients with chronic liver disease; Describe the problem of frailty; Review
methods of Hepatitis C diagnosis and staging; and Review current therapeutic Hepatitis C treatment options.

You’ll also learn about the following:

  • Causes of liver disease in the United States
  • Hepatitis C
  • The economics of treating hepatitis C
  • Transmission of hepatitis C

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Update on Adult Congenital Heart Disease

by

OSUWexnerbloglogo2014 Update on Adult Congenital Heart Disease. On this CME webcast, we’re going to update you on some of the unique challenges of diagnosing and treating adults with congenital heart disease. Joining our moderator in the studio is cardiologist and Assistant Professor of Internal Medicine, Dr. Saurabh Rajpal.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: INCREASE awareness about increasing prevalence of Adult Congenital Heart disease; and DISCUSS common congenital
heart disease diagnoses encountered in adult practice.

You’ll also learn about the following:

  • Common causes of congenital heart disease in adult patients
  • Changing prevalence of congenital heart disease in adults
  • Follow up testing and monitoring
  • Marfan syndrome

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.